NCT00112060 2014-03-31A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)Spectrum Pharmaceuticals, IncPhase 1/2 Withdrawn